Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLESENCE, INC.NANX · Entity 7041 | Chief Operating Officer | June 05, 2025 | June 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLESENCE, INC.
Report date June 05, 2025 · Filed June 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 196,905 |
Reported balance
After 2025-06-05 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2025-06-05 · Exercise / conversion · Acquired 4,693 · Balance 196,905 |
| Common StockSEC Table I · non-derivative | Direct | 192,212 |
Reported balance
After 2025-06-05 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2025-06-05 · Sale · Disposed 4,693 · Balance 192,212 F1: These 4,693 shares were sold through fifty trades at prices ranging from $3.95 to $3.99 per share. The average of all trades was $3.96 per share as shown. |
| Common StockSEC Table I · non-derivative | Direct | 231,019 |
Reported balance
After 2025-06-06 transaction · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · 2025-06-06 · Exercise / conversion · Acquired 38,807 · Balance 231,019 |
| Common StockSEC Table I · non-derivative | Direct | 192,212 |
Reported balance
After 2025-06-06 transaction · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · 2025-06-06 · Sale · Disposed 38,807 · Balance 192,212 F1: These 4,693 shares were sold through fifty trades at prices ranging from $3.95 to $3.99 per share. The average of all trades was $3.96 per share as shown. F2: These 38,807 shares were sold through one hundred forty-seven trades at prices ranging from $3.75 to $3.92 per share. The average of all trades was $3.80 per share as shown. |
| Common StockSEC Table I · non-derivative | Direct | 192,212 |
Reported balance
Holding disclosure · report date 2025-06-05 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 192,212 |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2026-02-23 | Direct | 0 |
Reported balance
After 2025-06-05 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2025-06-05 · Exercise / conversion · Disposed 4,693 · Balance 0 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.42 · Expires 2026-02-23 | Direct | 0 |
Reported balance
After 2025-06-06 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2025-06-06 · Exercise / conversion · Disposed 38,807 · Balance 0 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.68 · Expires 2027-02-21 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2025-06-05 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 50,000 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.82 · Expires 2028-05-23 | Direct | 80,000 |
Reported balance
Holding disclosure · report date 2025-06-05 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 80,000 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.51 · Expires 2029-05-22 | Direct | 16,500 |
Reported balance
Holding disclosure · report date 2025-06-05 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 16,500 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.45 · Expires 2027-06-18 | Direct | 90,000 |
Reported balance
Holding disclosure · report date 2025-06-05 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 90,000 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $4.17 · Expires 2028-12-28 | Direct | 90,000 |
Reported balance
Holding disclosure · report date 2025-06-05 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 90,000 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2029-12-20 | Direct | 72,000 |
Reported balance
Holding disclosure · report date 2025-06-05 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 72,000 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.61 · Expires 2030-12-27 | Direct | 12,600 |
Reported balance
Holding disclosure · report date 2025-06-05 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 12,600 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $2.44 · Expires 2031-12-31 | Direct | 22,500 |
Reported balance
Holding disclosure · report date 2025-06-05 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 22,500 F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
Filing footnotes · ownership attribution and instrument terms
F1: These 4,693 shares were sold through fifty trades at prices ranging from $3.95 to $3.99 per share. The average of all trades was $3.96 per share as shown.
F2: These 38,807 shares were sold through one hundred forty-seven trades at prices ranging from $3.75 to $3.92 per share. The average of all trades was $3.80 per share as shown.
F3: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2025 Filed Jun 6, 2025 23:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 38,807 | $0.42 Strike: $0.42 | $16,298.94 |
DisclosureSEC source: 0000950170-25-083345 · ownership.xml · derivative · entry 15 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,807 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 23:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 38,807 | $3.80 | $147,466.60 |
DisclosureSEC source: 0000950170-25-083345 · ownership.xml · nonDerivative · entry 5 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,212 F1 · shares: These 4,693 shares were sold through fifty trades at prices ranging from $3.95 to $3.99 per share. The average of all trades was $3.96 per share as shown. F2 · shares: These 38,807 shares were sold through one hundred forty-seven trades at prices ranging from $3.75 to $3.92 per share. The average of all trades was $3.80 per share as shown. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 23:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 38,807 | $0.42 | $16,298.94 |
DisclosureSEC source: 0000950170-25-083345 · ownership.xml · nonDerivative · entry 4 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 23:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 4,693 | $0.42 Strike: $0.42 | $1,971.06 |
DisclosureSEC source: 0000950170-25-083345 · ownership.xml · derivative · entry 14 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,693 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 23:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 4,693 | $3.96 | $18,584.28 |
DisclosureSEC source: 0000950170-25-083345 · ownership.xml · nonDerivative · entry 3 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,212 F1 · shares: These 4,693 shares were sold through fifty trades at prices ranging from $3.95 to $3.99 per share. The average of all trades was $3.96 per share as shown. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 23:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 4,693 | $0.42 | $1,971.06 |
DisclosureSEC source: 0000950170-25-083345 · ownership.xml · nonDerivative · entry 2 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2024 Filed Jan 13, 2025 22:19 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 22,500 | $2.44 Strike: $2.44 | $54,900.00 |
DisclosureSEC source: 0000950170-25-004903 · ownership.xml · derivative · entry 10 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2031-12-31 F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| September 23, 2024 Filed Sep 25, 2024 20:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 3,716 | $1.46 | $5,434.65 |
DisclosureSEC source: 0000950170-24-109326 · ownership.xml · nonDerivative · entry 2 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,212 Read SEC document |
| September 23, 2024 Filed Sep 25, 2024 20:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 1,000 | $1.57 | $1,570.00 |
DisclosureSEC source: 0000950170-24-109326 · ownership.xml · nonDerivative · entry 1 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,496 Read SEC document |
| June 24, 2024 Filed Jun 25, 2024 23:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 4,575 | $1.50 | $6,853.35 |
DisclosureSEC source: 0000950170-24-077505 · ownership.xml · nonDerivative · entry 6 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,496 Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 23:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 5,100 | $1.49 | $7,599.00 |
DisclosureSEC source: 0000950170-24-077505 · ownership.xml · nonDerivative · entry 5 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,921 Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 23:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 1,000 | $1.49 | $1,488.50 |
DisclosureSEC source: 0000950170-24-077505 · ownership.xml · nonDerivative · entry 4 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,821 Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 23:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 800 | $1.48 | $1,181.44 |
DisclosureSEC source: 0000950170-24-077505 · ownership.xml · nonDerivative · entry 3 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,821 Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 23:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 100 | $1.46 | $146.25 |
DisclosureSEC source: 0000950170-24-077505 · ownership.xml · nonDerivative · entry 2 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,021 Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 23:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 100 | $1.45 | $145.00 |
DisclosureSEC source: 0000950170-24-077505 · ownership.xml · nonDerivative · entry 1 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,921 Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 20:57 UTC | SOLESENCE, INC. NANX · Entity 7041 | Disposition to issuerCommon Stock (right to purchase) · Derivative | 50,000 | $0.44 Strike: $0.44 | $22,000.00 |
DisclosureSEC source: 0000950170-24-035990 · ownership.xml · derivative · entry 3 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2025-02-18 Read SEC document |
| March 21, 2024 Filed Mar 25, 2024 20:57 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 50,000 | $0.44 | $22,000.00 |
DisclosureSEC source: 0000950170-24-035990 · ownership.xml · nonDerivative · entry 1 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 22:54 UTC | SOLESENCE, INC. NANX · Entity 7041 | Disposition to issuerCommon Stock (right to purchase) · Derivative | 25,000 | $0.52 Strike: $0.52 | $13,000.00 |
DisclosureSEC source: 0001209191-24-002189 · doc4.xml · derivative · entry 2 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2024-02-13 F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 22:54 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 25,000 | $0.52 | $13,000.00 |
DisclosureSEC source: 0001209191-24-002189 · doc4.xml · nonDerivative · entry 1 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:00 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 12,600 | $0.61 Strike: $0.61 | $7,686.00 |
DisclosureSEC source: 0001209191-23-059980 · doc4.xml · derivative · entry 11 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,600 Underlying: Common Stock · 12,600 shares Expires 2030-12-27 F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| May 26, 2023 Filed Jun 6, 2023 00:02 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 23,410 | $1.19 | $27,857.90 |
DisclosureSEC source: 0001209191-23-034678 · doc4.xml · nonDerivative · entry 5 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,821 Read SEC document |
| May 19, 2023 Filed Jun 6, 2023 00:02 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 10,000 | $1.04 | $10,400.00 |
DisclosureSEC source: 0001209191-23-034678 · doc4.xml · nonDerivative · entry 4 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,411 Read SEC document |
| May 18, 2023 Filed Jun 6, 2023 00:02 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 15,590 | $1.04 | $16,213.60 |
DisclosureSEC source: 0001209191-23-034678 · doc4.xml · nonDerivative · entry 3 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,411 Read SEC document |
| May 17, 2023 Filed Jun 6, 2023 00:02 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 1,000 | $0.92 | $920.00 |
DisclosureSEC source: 0001209191-23-034678 · doc4.xml · nonDerivative · entry 2 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,821 Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 16:25 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 72,000 | $1.17 Strike: $1.17 | $83,880.00 |
DisclosureSEC source: 0001209191-22-062392 · doc4.xml · derivative · entry 10 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,000 Underlying: Common Stock · 72,000 shares Expires 2029-12-20 F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 17:43 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 90,000 | $4.17 Strike: $4.17 | $375,300.00 |
DisclosureSEC source: 0001209191-21-071579 · doc4.xml · derivative · entry 9 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2028-12-28 Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 01:09 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 25,000 | $0.52 Strike: $0.52 | $13,000.00 |
DisclosureSEC source: 0001209191-21-067223 · doc4.xml · derivative · entry 8 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 50,000 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Following the recently reported exercise of 12,393 shares (11/24/21), and the 2nd exercise of 12,607 shares (11/26/21, reported above) this line item represents the 3rd exercise, of 25,000 shares of the total initial grant of 75,000 shares, leaving a balance of 25,000 shares remaining relating to this grant. F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 01:09 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 24,000 | $0.42 Strike: $0.42 | $9,960.00 |
DisclosureSEC source: 0001209191-21-067223 · doc4.xml · derivative · entry 6 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2023-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Following recently reported exercises of 11,668 (11/22/21) and 12,332 (11/24/21) shares, this line item represents the 3rd exercise, of 24,000 shares of the total initial grant of 48,000 shares, leaving a balance of 0 shares remaining relating to this grant. F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 01:09 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 23,829 | $3.79 | $90,311.91 |
DisclosureSEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 5 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,821 Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 01:09 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 25,000 | $0.52 | $13,000.00 |
DisclosureSEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 4 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 01:09 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 24,000 | $0.42 | $9,960.00 |
DisclosureSEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 3 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2021 Filed Dec 1, 2021 01:09 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock · Derivative | 12,607 | $0.52 Strike: $0.52 | $6,555.64 |
DisclosureSEC source: 0001209191-21-067223 · doc4.xml · derivative · entry 7 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,607 shares Expires 2023-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Following the recently reported exercise of 12,393 shares (11/24/21), this line item represents the 2nd exercise, of 12,607 shares of a total initial grant of 75,000 shares, leaving a balance of 50,000 shares remaining relating to this grant, prior to the 11/30/21 exercise reported below. F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 26, 2021 Filed Dec 1, 2021 01:09 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 12,607 | $3.50 | $44,124.50 |
DisclosureSEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 2 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,650 Read SEC document |
| November 26, 2021 Filed Dec 1, 2021 01:09 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 12,607 | $0.52 | $6,555.64 |
DisclosureSEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 1 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 21:52 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 12,393 | $0.52 Strike: $0.52 | $6,444.36 |
DisclosureSEC source: 0001209191-21-066811 · doc4.xml · derivative · entry 8 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,607 Underlying: Common Stock · 75,000 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 21:52 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 12,332 | $0.42 Strike: $0.42 | $5,117.78 |
DisclosureSEC source: 0001209191-21-066811 · doc4.xml · derivative · entry 7 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 36,332 shares Expires 2023-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: This line item represents the 2nd sale, of 12,332 shares of a total initial grant of 48,000 shares, leaving a balance of 24,000 shares remaining relating to this grant. F3 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 21:52 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 24,725 | $3.77 | $93,213.25 |
DisclosureSEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 5 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,650 Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 21:52 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 12,393 | $0.52 | $6,444.36 |
DisclosureSEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 4 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2021 Filed Nov 24, 2021 21:52 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 12,332 | $0.42 | $5,117.78 |
DisclosureSEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 3 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:52 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 11,668 | $0.42 Strike: $0.42 | $4,842.22 |
DisclosureSEC source: 0001209191-21-066811 · doc4.xml · derivative · entry 6 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,668 shares Expires 2023-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This line item represents the 1st sale of 11,668 shares of a total grant of 48,000 shares, leaving a balance of 36,332 shares remaining relating to this grant. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:52 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 11,668 | $3.92 | $45,743.23 |
DisclosureSEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 2 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,650 Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:52 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 11,668 | $0.42 | $4,842.22 |
DisclosureSEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 1 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 22:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 1,200 | $2.26 | $2,712.00 |
DisclosureSEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 5 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,650 F2 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. The sales reported herein were effected in order to satisfy the costs of exercise and the required income tax withholdings. Read SEC document |
| September 16, 2021 Filed Sep 16, 2021 22:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 17,000 | $2.22 | $37,740.00 |
DisclosureSEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 4 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,850 F2 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. The sales reported herein were effected in order to satisfy the costs of exercise and the required income tax withholdings. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 22:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 5,350 | $2.30 | $12,305.00 |
DisclosureSEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 3 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,850 F2 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. The sales reported herein were effected in order to satisfy the costs of exercise and the required income tax withholdings. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 22:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock (right to purchase) · Derivative | 52,000 | $0.30 Strike: $0.30 | $15,600.00 |
DisclosureSEC source: 0001209191-21-056457 · doc4.xml · derivative · entry 6 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,000 shares Expires 2022-11-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. Subsequent to exercise, he plans to sell some of the shares exercised in order to satisfy the costs of exercise and the required income tax withholdings. F4 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 22:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | SaleCommon Stock | 2,800 | $2.30 | $6,440.00 |
DisclosureSEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 2 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,200 F2 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. The sales reported herein were effected in order to satisfy the costs of exercise and the required income tax withholdings. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 22:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | Exercise / conversionCommon Stock | 52,000 | $0.30 | $15,600.00 |
DisclosureSEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 1 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. Subsequent to exercise, he plans to sell some of the exercised shares reported herein in order to satisfy the costs of exercise and the required income tax withholdings. Read SEC document |
| June 18, 2020 Filed Jun 19, 2020 21:45 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 90,000 | $0.45 Strike: $0.45 | $40,500.00 |
DisclosureSEC source: 0001209191-20-038012 · doc4.xml · derivative · entry 9 Cureton Kevin · CIK 0001563513 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2027-06-18 F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
| May 22, 2019 Filed May 30, 2019 20:02 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantCommon Stock (right to purchase) · Derivative | 16,500 | $0.51 Strike: $0.51 | $8,415.00 |
DisclosureSEC source: 0001209191-19-033414 · doc4.xml · derivative · entry 8 Cureton Kevin · CIK 0001563513 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2029-05-22 F1 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.